Supreme Court Denies Certiorari In Antibiotic Patent Dispute

(May 31, 2016, 11:29 AM EDT) -- WASHINGTON, D.C. — A decision by a Delaware federal judge — later upheld by the Federal Circuit U.S. Court of Appeals — which invalidated four of five patents covering the antibiotic Cubicin will stand, thanks to a denial of certiorari on May 31 by the U.S. Supreme Court (Cubist Pharmaceuticals, Inc. v. Hospira, Inc., No. 15-1210, U.S. Sup.).

Justice Samuel Alito took no part in the consideration of Cubist Pharmaceuticals Inc.’s petition.

Bench Trial

In a 2012 complaint, Cubist alleged that pharmaceutical products proposed by Hospira...
To view the full article, register now.